INDIANAPOLIS, Oct. 8 /PRNewswire-FirstCall/ -- Windrose Medical Properties Trust , a self-managed specialty medical properties REIT, announced today that the underwriters of the Company’s recent public offering have exercised the over-allotment option to purchase 162,000 shares of common stock at the public offering price of $12.80 per share. As a result of the exercise, the Company will receive additional net proceeds, after underwriting discounts and commissions, of approximately $1.96 million, which will result in total net proceeds from the offering of approximately $20.01 million.
Robert W. Baird & Co. Incorporated, Ferris, Baker Watts, Inc., and Stifel, Nicolaus & Company, Inc. acted as underwriters and co-managers. Robert W. Baird & Co. Incorporated was sole book-running manager. J.J.B. Hilliard, W.L. Lyons Inc. also served as an underwriter.
The closing of the over-allotment option is expected to occur on October 13, 2004 and is subject to customary closing conditions.
Copies of the prospectus supplement relating to the offering may be obtained by contacting Robert W. Baird & Co. Incorporated, 777 East Wisconsin Avenue, Milwaukee, WI 53201.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale or an offer to buy these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
About Windrose
Windrose is a self-managed Real Estate Investment Trust (REIT) based in Indianapolis, Indiana with offices in Nashville, Tennessee. Windrose was formed to acquire, selectively develop and manage specialty medical properties, such as medical office buildings, outpatient treatment and diagnostic facilities, physician group practice clinics, ambulatory surgery centers and specialty hospitals and treatment centers.
Safe Harbor
Some of the statements in this news release constitute forward-looking statements. Such statements include, in particular, statements about our beliefs, expectations, plans and strategies that are not historical facts. You should not rely on our forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties, assumptions and changes in circumstances, many of which are beyond our control, which may cause our actual results to differ significantly from those expressed in any forward-looking statement. The factors that could cause actual results to differ materially from current expectations include financial performance and condition of our lessees, adverse changes in healthcare laws, changes in economic and general business conditions, competition for specialty medical properties, our ability to finance our operations, the availability of additional acquisitions, regulatory conditions and other factors described from time to time in filings we make with the Securities and Exchange Commission. The forward-looking statements contained herein represent our judgment as of the date hereof and we caution readers not to place undue reliance on such statements. We do not undertake to publicly update or revise any forward-looking statement whether as a result of new information, future events or otherwise.
For further information please contact: Fred Farrar, President and COO of Windrose Medical Properties Trust, +1-317-860-8213; or Investors/Media, Stephanie Carrington, +1-646-536-7017, scarrington@theruthgroup.com, or Jason Rando, +1-646-536-7025, jrando@theruthgroup.com, both of The Ruth Group, for Windrose Medical Properties Trust
Windrose Medical Properties Trust
CONTACT: Fred Farrar, President and COO of Windrose Medical PropertiesTrust, +1-317-860-8213; or Investors/Media, Stephanie Carrington,+1-646-536-7017, scarrington@theruthgroup.com, or Jason Rando,+1-646-536-7025, jrando@theruthgroup.com, both of The Ruth Group,for Windrose Medical Properties Trust
